Hypertension

Study Calls for Change in Prescribing Practices of Antihypertensive Agents in Patients with HIV

April 06, 2021

An analysis of more than 8000 patients with HIV and hypertension suggests these patients may not be receiving the most efficacious antihypertensive agents and this could be placing these patients at increased risk of cardiovascular disease events or death.

Treprostinil (Tyvaso) Receives FDA Approval for Pulmonary Hypertension Linked to Interstitial Lung Disease

April 01, 2021

The US FDA has granted a second approval to treprostinil (Tyvaso) inhalation solution, this time for the treatment of patients pulmonary hypertension associated with interstitial lung disease (PH-ILD) to help improve exercise ability.

Sotatercept Reduces Pulmonary Vascular Resistance in Patients with Pulmonary Arterial Hypertension

April 01, 2021

Results of the phase 2 PULSAR trial indicate sotatercept could be an effective adjunct to background medical therapy for reducing pulmonary vascular resistance in patients with pulmonary arterial hypertension.

Study Suggests Less than 5% of High-Risk Patients Screened for Primary Aldosteronism

March 22, 2021

A Michigan State University-led analysis suggests just 3% of patients at high risk for primary aldosteronism underwent screening for the hypertensive disorder.

Beta-Blockers Could Cause Sleep Disturbances, But Not Linked to Depression

March 16, 2021

A systematic review and meta-analysis of data from more than 280 studies is providing insight into the potential increase in risk of depression and other psychiatric adverse events associated with beta-blockers.

Study Finds Time-Restricted Diets Elicit No Changes in Blood Pressure or Lipid Profile

March 15, 2021

A recent study found that time-restricted diets did not induce changes in blood pressure or lipid profiles, but did lead to reductions in weight loss.

Risk Factor Prevalence Dangerously High, Poorly Controlled in Hispanic/Latino Adults

March 04, 2021

An analysis of data from more than 16k Hispanic/Latino individuals indicates the prevalence of cardiovascular risk factors among those with a history of stroke/TIA was greater than previously thought and many are unaware of these risk factors.

AHA Study Links 4 Major Conditions to More than 60% of COVID-19 Hospitalizations

February 25, 2021

An analysis using data from the CDC, COVID-NET, and the COVID Tracking Project suggests nearly 2 out of 3 COVID-19 hospitalizations in the US were attributable to obesity, hypertension, diabetes, and heart failure.

Large-Scale Genetic Analysis Indicates Increased Blood Pressure Causes Atrial Fibrillation

February 11, 2021

An analysis of data from the International Consortium of Blood Pressure-Genome Wide Association Studies suggests every 1 mmHg increase in blood pressure was linked to a 1.4-2.6% increase in risk of atrial fibrillation.

Paul D. Thompson, MD: Is Digoxin Back from the Dead?

January 13, 2021

In this column, Dr. Paul Thompson offers his perspective on the use of digoxin and explains why he has maintained use in certain patient populations despite its waning popularity in recent years.